US5143908A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antibacterial agents and potentiators of carbapenem antibiotics
Assignee: Merck and Co Inc
•
Filing: 1990-07-11
•
Granted: 1992-09-01
•
Expires: 2010-07-11
Abstract
Abstract New 3-(1-aminoalkylphosphinyl)-(2-substituted)propionic acids are described which display antibacterial activity and potentiate carbapenem antibiotics.
Inventors
- 👤 William H. Parsons
- 👤 William R. Schoen
- 👤 Arthur A. Patchett
- 👤 Masao Taniguchi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 18:09
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/28; C07F9/30; C07F9/32; C07F9/3205; C07F9/3241; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40; C07F9/301; C07F9/302; C07F9/303; C07F9/306; C07F9/3211; C07F9/3217; C07F9/547; C07F9/553; C07F9/576; C07F9/58
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
238 words
A pharmaceutical composition useful in the treatment of antibacterial infections which comprises a pharmaceutically acceptable carrier and a pharmaceutically effective amount to treat bacterial infections of an antibacterial compound of formula I: ##STR53## wherein R 1 is H, or CH 3 ; R 2 is (a) hydrogen; (b) C 1 -C 12 linear or branched alkyl; (c) C 1 -C 12 linear or branched monoalkenyl; (d) C 7 -C 20 aralkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and wherein said above values from R 2 can be substituted by one halo, hydroxy, carboxy, C 1 -C 4 alkoxycarbonyl, C 7 -C 16 arylalkoxycarbonyl, C 3 -C 7 cycloalkyl, C 1 -C 4 alkoxy, C 6 -C 12 aryloxy, amino, mono- or di-C 1 -C 8 alkylamino, thio, C 1 -C 4 alkylthio, C 6 -C 12 arylthio, C 7 -C 16 aralkylthio, or the radical --S--(CH 2 ) n --CH--(NH 2 )COOH, where n=1-2; with the proviso that R 2 is at least C 2 alkyl if substituted by one of the above-defined thio groups, and wherein the aryl ring can be further substituted by one C 1 -C 4 linear or branched alkyl, trihalomethyl, nitro, halo, cyano or sulfonamido; R 3 and R 4 are hydrogen, C 1 -C 4 alkyl; wherein the carbon atoms attached to R 1 are D(S) or DL(SR) and R 2 are D(R) or DL(RS) stereoconfiguration.
Claim 2
Dependent Claim
238 words
A pharmaceutical composition useful in the treatment of antibacterial infections which comprises a pharmaceutically acceptable carrier and a pharmaceutically effective amount to treat bacterial infections of an antibacterial compound of formula I: ##STR53## wherein R 1 is H, or CH 3 ; R 2 is (a) hydrogen; (b) C 1 -C 12 linear or branched alkyl; (c) C 1 -C 12 linear or branched monoalkenyl; (d) C 7 -C 20 aralkyl, wherein the alkyl chain is linear or branched C 1 -C 8 and wherein said above values from R 2 can be substituted by one halo, hydroxy, carboxy, C 1 -C 4 alkoxycarbonyl, C 7 -C 16 arylalkoxycarbonyl, C 3 -C 7 cycloalkyl, C 1 -C 4 alkoxy, C 6 -C 12 aryloxy, amino, mono- or di-C 1 -C 8 alkylamino, thio, C 1 -C 4 alkylthio, C 6 -C 12 arylthio, C 7 -C 16 aralkylthio, or the radical --S--(CH 2 ) n --CH--(NH 2 )COOH, where n=1-2; with the proviso that R 2 is at least C 2 alkyl if substituted by one of the above-defined thio groups, and wherein the aryl ring can be further substituted by one C 1 -C 4 linear or branched alkyl, trihalomethyl, nitro, halo, cyano or sulfonamido; R 3 and R 4 are hydrogen, C 1 -C 4 alkyl; wherein the carbon atoms attached to R 1 are D(S) or DL(SR) and R 2 are D(R) or DL(RS) stereoconfiguration.
Claim 3
Dependent Claim
25 words
The composition of claim 1 wherein the compound contains the carbon atoms attached to R 1 and R 2 in the D(S), D(R) configurations, respectively.
Claim 4
Dependent Claim
13 words
The composition of claim 1 in which the compound is 1-(aminoethyl)-(2-carboxy-n-propyl) phosphinic acid.
Claim 5
Dependent Claim
13 words
The composition of claim 1 in which the compound is 1-(aminoethyl)-(2-carbomethoxy-n-propyl) phosphinic acid.
Claim 6
Dependent Claim
13 words
The composition of claim 1 in which the compound is 1-(aminoethyl)-(2-carboxy-n-butyl) phosphinic acid.
Claim 7
Dependent Claim
13 words
The composition of claim 1 in which the compound is 1-(aminoethyl)-(2-carboxy-n-nonyl) phosphinic acid.
Claim 8
Dependent Claim
13 words
The composition of claim 1 in which the compound is 1-(aminoethyl)-(2-carboxy-3-chloro-n-propyl) phosphinic acid.
Claim 9
Dependent Claim
13 words
The composition of claim 1 in which the compound is 1-(aminoethyl)-(2-carboxy-3-bromo-n-propyl) phosphinic acid.
Claim 10
Dependent Claim
13 words
The composition of claim 1 in which the compound is 1-(aminoethyl)-(2-carboxy-n-hexyl) phosphinic acid.
Claim 11
Dependent Claim
30 words
A method for treating a bacterial infection in a mammalian host comprising administering to said host a therapeutically effective amount to treat bacterial infections of the composition of claim 1.
References Cited (Backward Citations)
US4147780A
Cited
US4160452A
Cited
US4256108A
Cited
US4265874A
Cited
US4539208A
Cited
US4374131A
Cited
US4416833A
Cited
EP0091594A1
Cited
EP0161546A1
Cited
EP0209848A2
Cited
EP0210545A2
Cited
US4715994A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-09-01 | 1996-03-02 | 1996-09-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-09-01 | 2000-03-02 | 2000-09-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-09-01 | 2004-03-02 | 2004-09-01 | $7700.00 | Window Closed / Lapsed |